Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Feb;58(2):163–174. doi: 10.1136/thorax.58.2.163

Pharmacotherapy and airway remodelling in asthma?

P Beckett 1, P Howarth 1
PMCID: PMC1746582  PMID: 12554904

Full Text

The Full Text of this article is available as a PDF (235.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agertoft L., Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994 May;88(5):373–381. doi: 10.1016/0954-6111(94)90044-2. [DOI] [PubMed] [Google Scholar]
  2. Aldridge R. E., Hancox R. J., Robin Taylor D., Cowan J. O., Winn M. C., Frampton C. M., Town G. I. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Respir Crit Care Med. 2000 May;161(5):1459–1464. doi: 10.1164/ajrccm.161.5.9906052. [DOI] [PubMed] [Google Scholar]
  3. Altraja A., Laitinen A., Virtanen I., Kämpe M., Simonsson B. G., Karlsson S. E., Håkansson L., Venge P., Sillastu H., Laitinen L. A. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol. 1996 Oct;15(4):482–488. doi: 10.1165/ajrcmb.15.4.8879182. [DOI] [PubMed] [Google Scholar]
  4. Amishima M., Munakata M., Nasuhara Y., Sato A., Takahashi T., Homma Y., Kawakami Y. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1907–1912. doi: 10.1164/ajrccm.157.6.9609040. [DOI] [PubMed] [Google Scholar]
  5. Backman K. S., Greenberger P. A., Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'. Chest. 1997 Nov 5;112(5):1234–1240. doi: 10.1378/chest.112.5.1234. [DOI] [PubMed] [Google Scholar]
  6. Bandi N., Kompella U. B. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol. 2001 Aug 10;425(2):109–116. doi: 10.1016/s0014-2999(01)01192-x. [DOI] [PubMed] [Google Scholar]
  7. Barnes P. J., Pauwels R. A. Theophylline in the management of asthma: time for reappraisal? Eur Respir J. 1994 Mar;7(3):579–591. doi: 10.1183/09031936.94.07030579. [DOI] [PubMed] [Google Scholar]
  8. Barnes P. J., Pedersen S., Busse W. W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1–53. doi: 10.1164/ajrccm.157.3.157315. [DOI] [PubMed] [Google Scholar]
  9. Beasley R., Roche W. R., Roberts J. A., Holgate S. T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989 Mar;139(3):806–817. doi: 10.1164/ajrccm/139.3.806. [DOI] [PubMed] [Google Scholar]
  10. Blyth D. I., Wharton T. F., Pedrick M. S., Savage T. J., Sanjar S. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol. 2000 Aug;23(2):241–246. doi: 10.1165/ajrcmb.23.2.3999. [DOI] [PubMed] [Google Scholar]
  11. Borger P., Hoekstra Y., Esselink M. T., Postma D. S., Zaagsma J., Vellenga E., Kauffman H. F. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol. 1998 Sep;19(3):400–407. doi: 10.1165/ajrcmb.19.3.2765. [DOI] [PubMed] [Google Scholar]
  12. Boulet L. P., Laviolette M., Turcotte H., Cartier A., Dugas M., Malo J. L., Boutet M. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest. 1997 Jul;112(1):45–52. doi: 10.1378/chest.112.1.45. [DOI] [PubMed] [Google Scholar]
  13. Boulet L. P., Turcotte H., Laviolette M., Naud F., Bernier M. C., Martel S., Chakir J. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1308–1313. doi: 10.1164/ajrccm.162.4.9910051. [DOI] [PubMed] [Google Scholar]
  14. Bousquet J., Jeffery P. K., Busse W. W., Johnson M., Vignola A. M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000 May;161(5):1720–1745. doi: 10.1164/ajrccm.161.5.9903102. [DOI] [PubMed] [Google Scholar]
  15. Bousquet J., Lacoste J. Y., Chanez P., Vic P., Godard P., Michel F. B. Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med. 1996 May;153(5):1648–1654. doi: 10.1164/ajrccm.153.5.8630616. [DOI] [PubMed] [Google Scholar]
  16. Bramley A. M., Roberts C. R., Schellenberg R. R. Collagenase increases shortening of human bronchial smooth muscle in vitro. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1513–1517. doi: 10.1164/ajrccm.152.5.7582286. [DOI] [PubMed] [Google Scholar]
  17. Brewster C. E., Howarth P. H., Djukanovic R., Wilson J., Holgate S. T., Roche W. R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1990 Nov;3(5):507–511. doi: 10.1165/ajrcmb/3.5.507. [DOI] [PubMed] [Google Scholar]
  18. Brown P. J., Greville H. W., Finucane K. E. Asthma and irreversible airflow obstruction. Thorax. 1984 Feb;39(2):131–136. doi: 10.1136/thx.39.2.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cade J. F., Pain M. C. Pulmonary function during clinical remission of asthma. How reversible is asthma? Aust N Z J Med. 1973 Dec;3(6):545–551. doi: 10.1111/j.1445-5994.1973.tb04293.x. [DOI] [PubMed] [Google Scholar]
  20. Carroll N. G., Cooke C., James A. L. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med. 1997 Feb;155(2):689–695. doi: 10.1164/ajrccm.155.2.9032214. [DOI] [PubMed] [Google Scholar]
  21. Chakir J., Laviolette M., Boutet M., Laliberté R., Dubé J., Boulet L. P. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest. 1996 Nov;75(5):735–744. [PubMed] [Google Scholar]
  22. Chetta A., Foresi A., Del Donno M., Bertorelli G., Pesci A., Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest. 1997 Apr;111(4):852–857. doi: 10.1378/chest.111.4.852. [DOI] [PubMed] [Google Scholar]
  23. Cho S. H., Seo J. Y., Choi D. C., Yoon H. J., Cho Y. J., Min K. U., Lee G. K., Seo J. W., Kim Y. Y. Pathological changes according to the severity of asthma. Clin Exp Allergy. 1996 Oct;26(10):1210–1219. doi: 10.1111/j.1365-2222.1996.tb00510.x. [DOI] [PubMed] [Google Scholar]
  24. Chong L. K., Cooper E., Vardey C. J., Peachell P. T. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Br J Pharmacol. 1998 Mar;123(5):1009–1015. doi: 10.1038/sj.bjp.0701703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cockcroft D. W., Murdock K. Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987 May;79(5):734–740. doi: 10.1016/0091-6749(87)90204-1. [DOI] [PubMed] [Google Scholar]
  26. Connolly C. K., Chan N. S., Prescott R. J. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J. 1988 Jun;64(752):422–425. doi: 10.1136/pgmj.64.752.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Crescioli S., Spinazzi A., Plebani M., Pozzani M., Mapp C. E., Boschetto P., Fabbri L. M. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy. 1991 Mar;66(3):245–251. [PubMed] [Google Scholar]
  28. Cronstein B. N., Kimmel S. C., Levin R. I., Martiniuk F., Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):9991–9995. doi: 10.1073/pnas.89.21.9991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. DUNNILL M. S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960 Jan;13:27–33. doi: 10.1136/jcp.13.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Daaka Y., Luttrell L. M., Lefkowitz R. J. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997 Nov 6;390(6655):88–91. doi: 10.1038/36362. [DOI] [PubMed] [Google Scholar]
  31. Davies D. E., Polosa R., Puddicombe S. M., Richter A., Holgate S. T. The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy. 1999 Aug;54(8):771–783. [PubMed] [Google Scholar]
  32. Dente F. L., Bancalari L., Bacci E., Bartoli M. L., Carnevali S., Cianchetti S., Di Franco A., Giannini D., Vagaggini B., Testi R. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax. 1999 Jul;54(7):622–624. doi: 10.1136/thx.54.7.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. DiCosmo B. F., Geba G. P., Picarella D., Elias J. A., Rankin J. A., Stripp B. R., Whitsett J. A., Flavell R. A. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest. 1994 Nov;94(5):2028–2035. doi: 10.1172/JCI117556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Diaz P., Galleguillos F. R., Gonzalez M. C., Pantin C. F., Kay A. B. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol. 1984 Jul;74(1):41–48. doi: 10.1016/0091-6749(84)90085-x. [DOI] [PubMed] [Google Scholar]
  35. Dixon E. R., Weinberg J. A., Lew D. B. Effect of dexamethasone on bovine airway smooth muscle cell proliferation. J Asthma. 1999 Sep;36(6):519–525. doi: 10.3109/02770909909054558. [DOI] [PubMed] [Google Scholar]
  36. Djukanović R., Finnerty J. P., Lee C., Wilson S., Madden J., Holgate S. T. The effects of theophylline on mucosal inflammation in asthmatic airways: biopsy results. Eur Respir J. 1995 May;8(5):831–833. [PubMed] [Google Scholar]
  37. Djukanović R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992 Mar;145(3):669–674. doi: 10.1164/ajrccm/145.3.669. [DOI] [PubMed] [Google Scholar]
  38. Dompeling E., van Schayck C. P., Molema J., Folgering H., van Grunsven P. M., van Weel C. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J. 1992 Sep;5(8):945–952. [PubMed] [Google Scholar]
  39. Dong Y., Aronsson M., Gustafsson J. A., Okret S. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem. 1989 Aug 15;264(23):13679–13683. [PubMed] [Google Scholar]
  40. Dunnill M. S., Massarella G. R., Anderson J. A. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax. 1969 Mar;24(2):176–179. doi: 10.1136/thx.24.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ebina M., Takahashi T., Chiba T., Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis. 1993 Sep;148(3):720–726. doi: 10.1164/ajrccm/148.3.720. [DOI] [PubMed] [Google Scholar]
  42. Eickelberg O., Roth M., Lörx R., Bruce V., Rüdiger J., Johnson M., Block L. H. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem. 1999 Jan 8;274(2):1005–1010. doi: 10.1074/jbc.274.2.1005. [DOI] [PubMed] [Google Scholar]
  43. Evans M. J., Guha S. C., Cox R. A., Moller P. C. Attenuated fibroblast sheath around the basement membrane zone in the trachea. Am J Respir Cell Mol Biol. 1993 Feb;8(2):188–192. doi: 10.1165/ajrcmb/8.2.188. [DOI] [PubMed] [Google Scholar]
  44. Fernandes D., Guida E., Koutsoubos V., Harris T., Vadiveloo P., Wilson J. W., Stewart A. G. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol. 1999 Jul;21(1):77–88. doi: 10.1165/ajrcmb.21.1.3396. [DOI] [PubMed] [Google Scholar]
  45. Gabazza E. C., Taguchi O., Tamaki S., Takeya H., Kobayashi H., Yasui H., Kobayashi T., Hataji O., Urano H., Zhou H. Thrombin in the airways of asthmatic patients. Lung. 1999;177(4):253–262. doi: 10.1007/pl00007645. [DOI] [PubMed] [Google Scholar]
  46. Gardiner P. V., Ward C., Booth H., Allison A., Hendrick D. J., Walters E. H. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med. 1994 Oct;150(4):1006–1011. doi: 10.1164/ajrccm.150.4.7921429. [DOI] [PubMed] [Google Scholar]
  47. Godfrey R. W., Lorimer S., Majumdar S., Adelroth E., Johnston P. W., Rogers A. V., Johansson S. A., Jeffery P. K. Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment. Eur Respir J. 1995 Jun;8(6):922–927. [PubMed] [Google Scholar]
  48. Grol M. H., Gerritsen J., Vonk J. M., Schouten J. P., Koëter G. H., Rijcken B., Postma D. S. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med. 1999 Dec;160(6):1830–1837. doi: 10.1164/ajrccm.160.6.9812100. [DOI] [PubMed] [Google Scholar]
  49. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  50. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Selroos O., Sovijärvi A. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994 Sep 15;331(11):700–705. doi: 10.1056/NEJM199409153311103. [DOI] [PubMed] [Google Scholar]
  51. Hancox R. J., Stevens D. A., Adcock I. M., Barnes P. J., Taylor D. R. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax. 1999 Jun;54(6):488–492. doi: 10.1136/thx.54.6.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Holgate S. T., Davies D. E., Lackie P. M., Wilson S. J., Puddicombe S. M., Lordan J. L. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):193–204. doi: 10.1016/s0091-6749(00)90066-6. [DOI] [PubMed] [Google Scholar]
  53. Hoshino M., Nakamura Y., Hamid Q. A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol. 2001 Jun;107(6):1034–1038. doi: 10.1067/mai.2001.115626. [DOI] [PubMed] [Google Scholar]
  54. Hoshino M., Nakamura Y., Sim J. J. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax. 1998 Jan;53(1):21–27. doi: 10.1136/thx.53.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hoshino M., Nakamura Y., Sim J. J., Yamashiro Y., Uchida K., Hosaka K., Isogai S. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy. 1998 May;28(5):568–577. doi: 10.1046/j.1365-2222.1998.00277.x. [DOI] [PubMed] [Google Scholar]
  56. Hoshino M., Nakamura Y., Sim J., Shimojo J., Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 1998 Nov;102(5):783–788. doi: 10.1016/s0091-6749(98)70018-1. [DOI] [PubMed] [Google Scholar]
  57. Hoshino M., Takahashi M., Takai Y., Sim J., Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy. 2001 May;31(5):722–730. doi: 10.1046/j.1365-2222.2001.01071.x. [DOI] [PubMed] [Google Scholar]
  58. Hoshino M., Takahashi M., Takai Y., Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):356–363. doi: 10.1016/s0091-6749(99)70379-9. [DOI] [PubMed] [Google Scholar]
  59. Huang J., Olivenstein R., Taha R., Hamid Q., Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med. 1999 Aug;160(2):725–729. doi: 10.1164/ajrccm.160.2.9809040. [DOI] [PubMed] [Google Scholar]
  60. Huang J., Olivenstein R., Taha R., Hamid Q., Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med. 1999 Aug;160(2):725–729. doi: 10.1164/ajrccm.160.2.9809040. [DOI] [PubMed] [Google Scholar]
  61. Hui K. K., Conolly M. E., Tashkin D. P. Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther. 1982 Nov;32(5):566–571. doi: 10.1038/clpt.1982.204. [DOI] [PubMed] [Google Scholar]
  62. Ignotz R. A., Endo T., Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987 May 15;262(14):6443–6446. [PubMed] [Google Scholar]
  63. Janknecht R., Hunter T. Transcription. A growing coactivator network. Nature. 1996 Sep 5;383(6595):22–23. doi: 10.1038/383022a0. [DOI] [PubMed] [Google Scholar]
  64. Jeffery P. K., Godfrey R. W., Adelroth E., Nelson F., Rogers A., Johansson S. A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):890–899. doi: 10.1164/ajrccm/145.4_Pt_1.890. [DOI] [PubMed] [Google Scholar]
  65. Jenkins C. R., Woolcock A. J. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax. 1988 May;43(5):378–384. doi: 10.1136/thx.43.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Jiang H., Rao K., Halayko A. J., Liu X., Stephens N. L. Ragweed sensitization-induced increase of myosin light chain kinase content in canine airway smooth muscle. Am J Respir Cell Mol Biol. 1992 Dec;7(6):567–573. doi: 10.1165/ajrcmb/7.6.567. [DOI] [PubMed] [Google Scholar]
  67. Johnson S. R., Knox A. J. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol Sci. 1997 Aug;18(8):288–292. doi: 10.1016/s0165-6147(97)01092-4. [DOI] [PubMed] [Google Scholar]
  68. Juniper E. F., Kline P. A., Vanzieleghem M. A., Hargreave F. E. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol. 1991 Feb;87(2):483–489. doi: 10.1016/0091-6749(91)90006-a. [DOI] [PubMed] [Google Scholar]
  69. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  70. Kidney J., Dominguez M., Taylor P. M., Rose M., Chung K. F., Barnes P. J. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med. 1995 Jun;151(6):1907–1914. doi: 10.1164/ajrccm.151.6.7767539. [DOI] [PubMed] [Google Scholar]
  71. Kondo H., Kasuga H., Noumura T. The heterogeneity of human fibroblasts as determined from the effects of hydrocortisone on cell growth and specific dexamethasone binding. Exp Cell Res. 1985 Jun;158(2):342–348. doi: 10.1016/0014-4827(85)90459-8. [DOI] [PubMed] [Google Scholar]
  72. Korn S. H., Jerre A., Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J. 2001 Jun;17(6):1070–1077. doi: 10.1183/09031936.01.00073301. [DOI] [PubMed] [Google Scholar]
  73. Kovacs E. J., DiPietro L. A. Fibrogenic cytokines and connective tissue production. FASEB J. 1994 Aug;8(11):854–861. doi: 10.1096/fasebj.8.11.7520879. [DOI] [PubMed] [Google Scholar]
  74. Kraft M., Lewis C., Pham D., Chu H. W. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol. 2001 Apr;107(4):602–606. doi: 10.1067/mai.2001.113760. [DOI] [PubMed] [Google Scholar]
  75. Laitinen A., Altraja A., Kämpe M., Linden M., Virtanen I., Laitinen L. A. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):951–958. doi: 10.1164/ajrccm.156.3.9610084. [DOI] [PubMed] [Google Scholar]
  76. Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
  77. Laitinen L. A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992 Jul;90(1):32–42. doi: 10.1016/s0091-6749(06)80008-4. [DOI] [PubMed] [Google Scholar]
  78. Laitinen L. A., Laitinen A., Heino M., Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis. 1991 Feb;143(2):423–427. doi: 10.1164/ajrccm/143.2.423. [DOI] [PubMed] [Google Scholar]
  79. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998 Oct 22;339(17):1194–1200. doi: 10.1056/NEJM199810223391703. [DOI] [PubMed] [Google Scholar]
  80. Levi-Schaffer F., Touitou E. Xanthines inhibit 3T3 fibroblast proliferation. Skin Pharmacol. 1991;4(4):286–290. doi: 10.1159/000210963. [DOI] [PubMed] [Google Scholar]
  81. Li X., Ward C., Thien F., Bish R., Bamford T., Bao X., Bailey M., Wilson J. W., Haydn Walters E. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1493–1499. doi: 10.1164/ajrccm.160.5.9811052. [DOI] [PubMed] [Google Scholar]
  82. Li X., Wilson J. W. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med. 1997 Jul;156(1):229–233. doi: 10.1164/ajrccm.156.1.9607066. [DOI] [PubMed] [Google Scholar]
  83. Lilly C. M., Bai T. R., Shore S. A., Hall A. E., Drazen J. M. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):548–553. doi: 10.1164/ajrccm.151.2.7531100. [DOI] [PubMed] [Google Scholar]
  84. Lundgren R., Söderberg M., Hörstedt P., Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J. 1988 Dec;1(10):883–889. [PubMed] [Google Scholar]
  85. Löwhagen O., Rak S. Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol. 1985 Apr;75(4):460–467. doi: 10.1016/s0091-6749(85)80018-x. [DOI] [PubMed] [Google Scholar]
  86. Macklem P. T. A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med. 1996 Jan;153(1):83–89. doi: 10.1164/ajrccm.153.1.8542167. [DOI] [PubMed] [Google Scholar]
  87. Magnan A., Retornaz F., Tsicopoulos A., Brisse J., Van Pee D., Gosset P., Chamlian A., Tonnel A. B., Vervloet D. Altered compartmentalization of transforming growth factor-beta in asthmatic airways. Clin Exp Allergy. 1997 Apr;27(4):389–395. [PubMed] [Google Scholar]
  88. Manolitsas N. D., Wang J., Devalia J. L., Trigg C. J., McAulay A. E., Davies R. J. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med. 1995 Jun;151(6):1925–1930. doi: 10.1164/ajrccm.151.6.7767541. [DOI] [PubMed] [Google Scholar]
  89. Mapp C., Boschetto P., dal Vecchio L., Crescioli S., de Marzo N., Paleari D., Fabbri L. M. Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects. Am Rev Respir Dis. 1987 Dec;136(6):1403–1407. doi: 10.1164/ajrccm/136.6.1403. [DOI] [PubMed] [Google Scholar]
  90. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597–641. doi: 10.1146/annurev.cb.06.110190.003121. [DOI] [PubMed] [Google Scholar]
  91. Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990 Apr;6(4):121–125. doi: 10.1016/0168-9525(90)90126-q. [DOI] [PubMed] [Google Scholar]
  92. Mauad T., Xavier A. C., Saldiva P. H., Dolhnikoff M. Elastosis and fragmentation of fibers of the elastic system in fatal asthma. Am J Respir Crit Care Med. 1999 Sep;160(3):968–975. doi: 10.1164/ajrccm.160.3.9809088. [DOI] [PubMed] [Google Scholar]
  93. McCoy B. J., Diegelmann R. F., Cohen I. K. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med. 1980 Feb;163(2):216–222. doi: 10.3181/00379727-163-40750. [DOI] [PubMed] [Google Scholar]
  94. Meisler N., Keefer K. A., Ehrlich H. P., Yager D. R., Myers-Parrelli J., Cutroneo K. R. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol. 1997 Mar;108(3):285–289. doi: 10.1111/1523-1747.ep12286461. [DOI] [PubMed] [Google Scholar]
  95. Minoo P., King R. J. Epithelial-mesenchymal interactions in lung development. Annu Rev Physiol. 1994;56:13–45. doi: 10.1146/annurev.ph.56.030194.000305. [DOI] [PubMed] [Google Scholar]
  96. Minshall E. M., Leung D. Y., Martin R. J., Song Y. L., Cameron L., Ernst P., Hamid Q. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1997 Sep;17(3):326–333. doi: 10.1165/ajrcmb.17.3.2733. [DOI] [PubMed] [Google Scholar]
  97. Moreno R. H., Hogg J. C., Paré P. D. Mechanics of airway narrowing. Am Rev Respir Dis. 1986 Jun;133(6):1171–1180. doi: 10.1164/arrd.1986.133.6.1171. [DOI] [PubMed] [Google Scholar]
  98. Morishima Y., Nomura A., Uchida Y., Noguchi Y., Sakamoto T., Ishii Y., Goto Y., Masuyama K., Zhang M. J., Hirano K. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol. 2001 Jan;24(1):1–11. doi: 10.1165/ajrcmb.24.1.4040. [DOI] [PubMed] [Google Scholar]
  99. Munoz N. M., Vita A. J., Neeley S. P., McAllister K., Spaethe S. M., White S. R., Leff A. R. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. J Pharmacol Exp Ther. 1994 Jan;268(1):139–143. [PubMed] [Google Scholar]
  100. Murphy G., Docherty A. J. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992 Aug;7(2):120–125. doi: 10.1165/ajrcmb/7.2.120. [DOI] [PubMed] [Google Scholar]
  101. Nakamura Y., Hoshino M., Sim J. J., Ishii K., Hosaka K., Sakamoto T. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax. 1998 Oct;53(10):835–841. doi: 10.1136/thx.53.10.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. O'Connor C. M., FitzGerald M. X. Matrix metalloproteases and lung disease. Thorax. 1994 Jun;49(6):602–609. doi: 10.1136/thx.49.6.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. O'Hickey S. P., Hawksworth R. J., Fong C. Y., Arm J. P., Spur B. W., Lee T. H. Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways. Am Rev Respir Dis. 1991 Nov;144(5):1053–1057. doi: 10.1164/ajrccm/144.5.1053. [DOI] [PubMed] [Google Scholar]
  104. Ohno I., Nitta Y., Yamauchi K., Hoshi H., Honma M., Woolley K., O'Byrne P., Tamura G., Jordana M., Shirato K. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol. 1996 Sep;15(3):404–409. doi: 10.1165/ajrcmb.15.3.8810646. [DOI] [PubMed] [Google Scholar]
  105. Olivieri D., Chetta A., Del Donno M., Bertorelli G., Casalini A., Pesci A., Testi R., Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med. 1997 Jun;155(6):1864–1871. doi: 10.1164/ajrccm.155.6.9196087. [DOI] [PubMed] [Google Scholar]
  106. Ollerenshaw S. L., Jarvis D., Sullivan C. E., Woolcock A. J. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J. 1991 Jun;4(6):673–682. [PubMed] [Google Scholar]
  107. Ollerenshaw S., Jarvis D., Woolcock A., Sullivan C., Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med. 1989 May 11;320(19):1244–1248. doi: 10.1056/NEJM198905113201904. [DOI] [PubMed] [Google Scholar]
  108. Orsida B. E., Ward C., Li X., Bish R., Wilson J. W., Thien F., Walters E. H. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med. 2001 Jul 1;164(1):117–121. doi: 10.1164/ajrccm.164.1.2006003. [DOI] [PubMed] [Google Scholar]
  109. Overall C. M., Wrana J. L., Sodek J. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Connect Tissue Res. 1989;20(1-4):289–294. doi: 10.3109/03008208909023899. [DOI] [PubMed] [Google Scholar]
  110. Overbeek S. E., Kerstjens H. A., Bogaard J. M., Mulder P. G., Postma D. S. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups. Chest. 1996 Jul;110(1):35–41. doi: 10.1378/chest.110.1.35. [DOI] [PubMed] [Google Scholar]
  111. Panettieri R. A., Tan E. M., Ciocca V., Luttmann M. A., Leonard T. B., Hay D. W. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol. 1998 Sep;19(3):453–461. doi: 10.1165/ajrcmb.19.3.2999. [DOI] [PubMed] [Google Scholar]
  112. Pang L., Knox A. J. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J. 2001 Jan;15(1):261–269. doi: 10.1096/fj.00-0103com. [DOI] [PubMed] [Google Scholar]
  113. Pang L., Knox A. J. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol. 2000 Jul;23(1):79–85. doi: 10.1165/ajrcmb.23.1.3985. [DOI] [PubMed] [Google Scholar]
  114. Paré P. D., Roberts C. R., Bai T. R., Wiggs B. J. The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis. 1997 Dec;52(6):589–596. [PubMed] [Google Scholar]
  115. Pauwels R. A., Löfdahl C. G., Postma D. S., Tattersfield A. E., O'Byrne P., Barnes P. J., Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997 Nov 13;337(20):1405–1411. doi: 10.1056/NEJM199711133372001. [DOI] [PubMed] [Google Scholar]
  116. Peat J. K., Woolcock A. J., Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987 Mar;70(3):171–179. [PubMed] [Google Scholar]
  117. Pesci A., Balbi B., Majori M., Cacciani G., Bertacco S., Alciato P., Donner C. F. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 1998 Aug;12(2):380–386. doi: 10.1183/09031936.98.12020380. [DOI] [PubMed] [Google Scholar]
  118. Peters M. J., Adcock I. M., Brown C. R., Barnes P. J. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol. 1995 Apr 28;289(2):275–281. doi: 10.1016/0922-4106(95)90104-3. [DOI] [PubMed] [Google Scholar]
  119. Peñuelas I., Encío I. J., López-Moratalla N., Santiago E. cAMP activates transcription of the human glucocorticoid receptor gene promoter. J Steroid Biochem Mol Biol. 1998 Oct;67(2):89–94. doi: 10.1016/s0960-0760(98)00097-1. [DOI] [PubMed] [Google Scholar]
  120. Priestley G. C., Brown J. C. Effects of corticosteroids on the proliferation of normal and abnormal human connective tissue cells. Br J Dermatol. 1980 Jan;102(1):35–41. doi: 10.1111/j.1365-2133.1980.tb05669.x. [DOI] [PubMed] [Google Scholar]
  121. Puddicombe S. M., Polosa R., Richter A., Krishna M. T., Howarth P. H., Holgate S. T., Davies D. E. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000 Jul;14(10):1362–1374. doi: 10.1096/fj.14.10.1362. [DOI] [PubMed] [Google Scholar]
  122. Rabe K. F., Dent G. Theophylline and airway inflammation. Clin Exp Allergy. 1998 Aug;28 (Suppl 3):35–41. [PubMed] [Google Scholar]
  123. Reddy K. B., Howe P. H. Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol. 1993 Jul;156(1):48–55. doi: 10.1002/jcp.1041560108. [DOI] [PubMed] [Google Scholar]
  124. Redington A. E., Madden J., Frew A. J., Djukanovic R., Roche W. R., Holgate S. T., Howarth P. H. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):642–647. doi: 10.1164/ajrccm.156.2.9605065. [DOI] [PubMed] [Google Scholar]
  125. Redington A. E., Roche W. R., Holgate S. T., Howarth P. H. Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects. J Pathol. 1998 Dec;186(4):410–415. doi: 10.1002/(SICI)1096-9896(199812)186:4<410::AID-PATH198>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  126. Redlich C. A., Delisser H. M., Elias J. A. Retinoic acid inhibition of transforming growth factor-beta-induced collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol. 1995 Mar;12(3):287–295. doi: 10.1165/ajrcmb.12.3.7873195. [DOI] [PubMed] [Google Scholar]
  127. Redline S., Tager I. B., Segal M. R., Gold D., Speizer F. E., Weiss S. T. The relationship between longitudinal change in pulmonary function and nonspecific airway responsiveness in children and young adults. Am Rev Respir Dis. 1989 Jul;140(1):179–184. doi: 10.1164/ajrccm/140.1.179. [DOI] [PubMed] [Google Scholar]
  128. Roberts J. A., Bradding P., Britten K. M., Walls A. F., Wilson S., Gratziou C., Holgate S. T., Howarth P. H. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J. 1999 Aug;14(2):275–282. doi: 10.1034/j.1399-3003.1999.14b07.x. [DOI] [PubMed] [Google Scholar]
  129. Roche W. R., Beasley R., Williams J. H., Holgate S. T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989 Mar 11;1(8637):520–524. doi: 10.1016/s0140-6736(89)90067-6. [DOI] [PubMed] [Google Scholar]
  130. Rogers Duncan F. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? Clin Exp Allergy. 2002 Aug;32(8):1124–1127. doi: 10.1046/j.1365-2745.2002.01474.x. [DOI] [PubMed] [Google Scholar]
  131. Rokowski R. J., Sheehy J., Cutroneo K. R. Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys. 1981 Aug;210(1):74–81. doi: 10.1016/0003-9861(81)90165-x. [DOI] [PubMed] [Google Scholar]
  132. Rosenthal R. R., Busse W. W., Kemp J. P., Baker J. W., Kalberg C., Emmett A., Rickard K. A. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Chest. 1999 Sep;116(3):595–602. doi: 10.1378/chest.116.3.595. [DOI] [PubMed] [Google Scholar]
  133. Ruoss S. J., Hartmann T., Caughey G. H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest. 1991 Aug;88(2):493–499. doi: 10.1172/JCI115330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Rutherford R. B., TrailSmith M. D., Ryan M. E., Charette M. F. Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. Arch Oral Biol. 1992 Feb;37(2):139–145. doi: 10.1016/0003-9969(92)90009-w. [DOI] [PubMed] [Google Scholar]
  135. Scarcériaux V., Pélaprat D., Forgez P., Lhiaubet A. M., Rostène W. Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures. Endocrinology. 1995 Jun;136(6):2554–2560. doi: 10.1210/endo.136.6.7750477. [DOI] [PubMed] [Google Scholar]
  136. Schachter E. N., Doyle C. A., Beck G. J. A prospective study of asthma in a rural community. Chest. 1984 May;85(5):623–630. doi: 10.1378/chest.85.5.623. [DOI] [PubMed] [Google Scholar]
  137. Seldon P. M., Barnes P. J., Meja K., Giembycz M. A. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol Pharmacol. 1995 Oct;48(4):747–757. [PubMed] [Google Scholar]
  138. Selroos O., Pietinalho A., Löfroos A. B., Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995 Nov;108(5):1228–1234. doi: 10.1378/chest.108.5.1228. [DOI] [PubMed] [Google Scholar]
  139. Shiels I. A., Bowler S. D., Taylor S. M. The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells. Inflammation. 1999 Aug;23(4):321–331. doi: 10.1023/a:1020257532357. [DOI] [PubMed] [Google Scholar]
  140. Shrewsbury S., Pyke S., Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ. 2000 May 20;320(7246):1368–1373. doi: 10.1136/bmj.320.7246.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Shull S., Meisler N., Absher M., Phan S., Cutroneo K. Glucocorticoid-induced down regulation of transforming growth factor-beta 1 in adult rat lung fibroblasts. Lung. 1995;173(2):71–78. doi: 10.1007/BF02981467. [DOI] [PubMed] [Google Scholar]
  142. Silvestri M., Fregonese L., Sabatini F., Dasic G., Rossi G. A. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J. 2001 Jul;18(1):139–145. doi: 10.1183/09031936.01.00067901. [DOI] [PubMed] [Google Scholar]
  143. Sobonya R. E. Quantitative structural alterations in long-standing allergic asthma. Am Rev Respir Dis. 1984 Aug;130(2):289–292. doi: 10.1164/arrd.1984.130.2.289. [DOI] [PubMed] [Google Scholar]
  144. Sont J. K., Willems L. N., Bel E. H., van Krieken J. H., Vandenbroucke J. P., Sterk P. J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1043–1051. doi: 10.1164/ajrccm.159.4.9806052. [DOI] [PubMed] [Google Scholar]
  145. Spoelstra F. M., Postma D. S., Hovenga H., Noordhoek J. A., Kauffman H. F. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax. 2002 Mar;57(3):237–241. doi: 10.1136/thorax.57.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Springall D. R., Howarth P. H., Counihan H., Djukanovic R., Holgate S. T., Polak J. M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet. 1991 Mar 23;337(8743):697–701. doi: 10.1016/0140-6736(91)90279-x. [DOI] [PubMed] [Google Scholar]
  147. Stewart A. G., Fernandes D., Tomlinson P. R. The effect of glucocorticoids on proliferation of human cultured airway smooth muscle. Br J Pharmacol. 1995 Dec;116(8):3219–3226. doi: 10.1111/j.1476-5381.1995.tb15127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Stewart A. G., Tomlinson P. R., Wilson J. W. Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br J Pharmacol. 1997 Jun;121(3):361–368. doi: 10.1038/sj.bjp.0701128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Sullivan P., Bekir S., Jaffar Z., Page C., Jeffery P., Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet. 1994 Apr 23;343(8904):1006–1008. doi: 10.1016/s0140-6736(94)90127-9. [DOI] [PubMed] [Google Scholar]
  150. Tang W., Geba G. P., Zheng T., Ray P., Homer R. J., Kuhn C., 3rd, Flavell R. A., Elias J. A. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest. 1996 Dec 15;98(12):2845–2853. doi: 10.1172/JCI119113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Temann U. A., Geba G. P., Rankin J. A., Flavell R. A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med. 1998 Oct 5;188(7):1307–1320. doi: 10.1084/jem.188.7.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Tomlinson P. R., Wilson J. W., Stewart A. G. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol. 1995 Jun 16;49(12):1809–1819. doi: 10.1016/0006-2952(94)00532-q. [DOI] [PubMed] [Google Scholar]
  153. Trigg C. J., Manolitsas N. D., Wang J., Calderón M. A., McAulay A., Jordan S. E., Herdman M. J., Jhalli N., Duddle J. M., Hamilton S. A. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med. 1994 Jul;150(1):17–22. doi: 10.1164/ajrccm.150.1.8025745. [DOI] [PubMed] [Google Scholar]
  154. Twentyman O. P., Finnerty J. P., Harris A., Palmer J., Holgate S. T. Protection against allergen-induced asthma by salmeterol. Lancet. 1990 Dec 1;336(8727):1338–1342. doi: 10.1016/0140-6736(90)92894-n. [DOI] [PubMed] [Google Scholar]
  155. Ulrik C. S., Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994 Sep;150(3):629–634. doi: 10.1164/ajrccm.150.3.8087330. [DOI] [PubMed] [Google Scholar]
  156. Van Eerdewegh Paul, Little Randall D., Dupuis Josée, Del Mastro Richard G., Falls Kathy, Simon Jason, Torrey Dana, Pandit Sunil, McKenny Joyce, Braunschweiger Karen. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 2002 Jul 10;418(6896):426–430. doi: 10.1038/nature00878. [DOI] [PubMed] [Google Scholar]
  157. Vanacker N. J., Palmans E., Kips J. C., Pauwels R. A. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):674–679. doi: 10.1164/ajrccm.163.3.2004160. [DOI] [PubMed] [Google Scholar]
  158. Vathenen A. S., Knox A. J., Wisniewski A., Tattersfield A. E. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991 Jun;143(6):1317–1321. doi: 10.1164/ajrccm/143.6.1317. [DOI] [PubMed] [Google Scholar]
  159. Vignola A. M., Chanez P., Chiappara G., Merendino A., Pace E., Rizzo A., la Rocca A. M., Bellia V., Bonsignore G., Bousquet J. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):591–599. doi: 10.1164/ajrccm.156.2.9609066. [DOI] [PubMed] [Google Scholar]
  160. Vignola A. M., Merendino A. M., Chiappara G., Chanez P., Pace E., Siena L., Profita M., Bousquet J., Bonsignore G. Markers of acute airway inflammation. Monaldi Arch Chest Dis. 1997 Feb;52(1):83–85. [PubMed] [Google Scholar]
  161. Vignola A. M., Riccobono L., Mirabella A., Profita M., Chanez P., Bellia V., Mautino G., D'accardi P., Bousquet J., Bonsignore G. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1998 Dec;158(6):1945–1950. doi: 10.1164/ajrccm.158.6.9803014. [DOI] [PubMed] [Google Scholar]
  162. Wallin A., Sandström T., Söderberg M., Howarth P., Lundbäck B., Della-Cioppa G., Wilson S., Judd M., Djukanović R., Holgate S. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med. 1999 Jan;159(1):79–86. doi: 10.1164/ajrccm.159.1.9801007. [DOI] [PubMed] [Google Scholar]
  163. Wang C. G., Du T., Xu L. J., Martin J. G. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis. 1993 Aug;148(2):413–417. doi: 10.1164/ajrccm/148.2.413. [DOI] [PubMed] [Google Scholar]
  164. Ward A. J., McKenniff M., Evans J. M., Page C. P., Costello J. F. Theophylline--an immunomodulatory role in asthma? Am Rev Respir Dis. 1993 Mar;147(3):518–523. doi: 10.1164/ajrccm/147.3.518. [DOI] [PubMed] [Google Scholar]
  165. Wiggs B. R., Bosken C., Paré P. D., James A., Hogg J. C. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Jun;145(6):1251–1258. doi: 10.1164/ajrccm/145.6.1251. [DOI] [PubMed] [Google Scholar]
  166. Wiggs B. R., Hrousis C. A., Drazen J. M., Kamm R. D. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol (1985) 1997 Dec;83(6):1814–1821. doi: 10.1152/jappl.1997.83.6.1814. [DOI] [PubMed] [Google Scholar]
  167. Wiggs B. R., Moreno R., Hogg J. C., Hilliam C., Paré P. D. A model of the mechanics of airway narrowing. J Appl Physiol (1985) 1990 Sep;69(3):849–860. doi: 10.1152/jappl.1990.69.3.849. [DOI] [PubMed] [Google Scholar]
  168. Wilson S. J., Wallin A., Della-Cioppa G., Sandström T., Holgate S. T. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1047–1052. doi: 10.1164/ajrccm.164.6.2010045. [DOI] [PubMed] [Google Scholar]
  169. Wood R. A., Johnson E. F., Van Natta M. L., Chen P. H., Eggleston P. A. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med. 1998 Jul;158(1):115–120. doi: 10.1164/ajrccm.158.1.9712110. [DOI] [PubMed] [Google Scholar]
  170. Woolcock A. J., Yan K., Salome C. M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy. 1988 Mar;18(2):165–176. doi: 10.1111/j.1365-2222.1988.tb02856.x. [DOI] [PubMed] [Google Scholar]
  171. Young P. G., Skinner S. J., Black P. N. Effects of glucocorticoids and beta-adrenoceptor agonists on the proliferation of airway smooth muscle. Eur J Pharmacol. 1995 Jan 24;273(1-2):137–143. doi: 10.1016/0014-2999(94)00679-2. [DOI] [PubMed] [Google Scholar]
  172. Zhu Z., Homer R. J., Wang Z., Chen Q., Geba G. P., Wang J., Zhang Y., Elias J. A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999 Mar;103(6):779–788. doi: 10.1172/JCI5909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. van Essen-Zandvliet E. E., Hughes M. D., Waalkens H. J., Duiverman E. J., Pocock S. J., Kerrebijn K. F. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992 Sep;146(3):547–554. doi: 10.1164/ajrccm/146.3.547. [DOI] [PubMed] [Google Scholar]
  174. van de Stolpe A., Caldenhoven E., Raaijmakers J. A., van der Saag P. T., Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol. 1993 Mar;8(3):340–347. doi: 10.1165/ajrcmb/8.3.340. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES